Patient
SITE010-0205
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE010 (ESP) (Dr. Silva)
consented 2026-05-04
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-08-09
Grade 2 Pruritus — outcome: RECOVERED/RESOLVED; onset 2023-02-02 (study day 88); relationship: not assessed
severe
assessed
2026-06-04
Grade 3 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-11-28 (study day 22); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.